JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment.
about
Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert groupNeurological immune reconstitution inflammatory response: riding the tide of immune recoveryRisk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple SclerosisJC virus granule cell neuronopathy onset two months after chemotherapy for low-grade lymphomaA fatal case of JC virus meningitis presenting with hydrocephalus in a human immunodeficiency virus-seronegative patientJCV GCN in a natalizumab-treated MS patient is associated with mutations of the VP1 capsid gene.Novel syndromes associated with JC virus infection of neurons and meningeal cells: no longer a gray areaHeterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literature.Case report of a patient with progressive multifocal leukoencephalopathy under treatment with dimethyl fumarateLack of Major Histocompatibility Complex Class I Upregulation and Restrictive Infection by JC Virus Hamper Detection of Neurons by T Lymphocytes in the Central Nervous System.Simian Virus 40 Infection in the Spinal Cord of Simian Immunodeficiency Virus-Immunosuppressed Rhesus MacaquesBroadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathyConcomitant granule cell neuronopathy in patients with natalizumab-associated PMLImmunology of progressive multifocal leukoencephalopathy.JC Virus Infects Neurons and Glial Cells in the Hippocampus.Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).Balancing Early Aggression Against Risk of Progression in Multiple Sclerosis.Natalizumab in relapsing-remitting multiple sclerosis.MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance.Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.Natalizumab granule cell neuronopathy: FDG-PET in diagnosis and immune reconstitution with G-CSF.MRI pattern in asymptomatic natalizumab-associated PML.Gone over to the dark side: Natalizumab-associated JC virus infection of neurons in cerebellar gray matter.Progressive ataxia in a natalizumab-treated multiple sclerosis patient: the dark side of JC virus infection.VZV-associated acute retinal necrosis in a patient with MS treated with natalizumab.
P2860
Q26780412-CB00141F-D950-42ED-8113-D629D0D58106Q28082309-4C5CBE61-A844-41F9-9087-65A4427DE589Q28087414-54947495-B745-4983-AB90-E63C35913DF7Q33827403-149E23EB-9278-4DBB-99AD-2E41BE97A6A7Q33956020-866F50A9-569D-4946-A8E3-035078F15225Q34112987-8BF11EC5-BB71-4446-B5C0-B78860B2DAA6Q34472405-7CC981BB-5F6C-48BF-8FA5-3A069B7AA598Q35314514-AAD18FCF-7F73-4D34-9DD8-1E565E58BE9FQ35685505-2F51545A-5537-4E46-83C0-D2EF124E274AQ35864067-7C2E9EFA-CBBF-43AD-B13A-9C42B1A25220Q36175401-1606B5E2-2BDB-40E2-BD6D-7C0852936899Q36764988-FF6A9B06-BA04-40A5-912A-1033D1C50227Q36783871-F1FB114E-E849-47BA-8298-FBED1D657F19Q38367755-BD33D1C3-9215-418C-A1BC-CF9642AF4ADEQ38379787-23F7D22C-BF84-4236-A1EB-3D00CBC8984EQ38577593-DE810ADF-9495-4EA6-88B2-91097FD132E5Q38649412-B595C128-8D00-4C5D-A584-8EAEF0AA75F1Q38786252-CAD29602-1029-44E6-8C9A-C8322BBDAB9DQ40619670-37EBC5AB-AE32-43A9-8646-7553444E16AAQ40792696-092C2F21-8BEE-483D-8A68-5489C4E8897AQ41048876-5A8FAD24-B05A-439D-8C9D-72C1A0237615Q41745436-A66E30F5-FAAF-4DB5-8EC3-9654F71CCC57Q42561798-A0E0006E-E1E7-4049-A29F-EFBA277B7AA2Q45335555-0A03428D-8F89-458D-9637-0CA48896A7B1Q55561425-05FA2BE7-94F5-40F3-83E6-66E8FFDE8D05
P2860
JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment.
@en
JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment.
@nl
type
label
JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment.
@en
JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment.
@nl
prefLabel
JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment.
@en
JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment.
@nl
P2093
P2860
P50
P356
P1433
P1476
JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment.
@en
P2093
Adriano Bont
Christian Kempf
Fabian Büchele
Michael Linnebank
Roland Martin
Sven Schippling
P2860
P304
P356
10.1002/ANA.23973
P577
2013-09-16T00:00:00Z